Discovery of novel thiourea derivatives as potent and selective β3-adrenergic receptor agonists

被引：13

作者：

Maruyama, Tatsuya ^{[1
]}

Seki, Norio ^{[1
]}

Onda, Kenichi ^{[1
]}

Suzuki, Takayuki ^{[1
]}

Kawazoe, Souichirou ^{[1
]}

Hayakawa, Masahiko ^{[1
]}

Matsui, Tetsuo ^{[1
]}

Takasu, Toshiyuki ^{[1
]}

Ohta, Mitsuaki ^{[1
]}

机构：

[1] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 15期

关键词：

beta 3-Adrenergic receptor; Agonist; Thiourea; Phenoxypropanolamine; Diabetes; BETA(3) ADRENERGIC-RECEPTOR; HUMAN DETRUSOR MUSCLE; BETA(3)-ADRENOCEPTOR AGONISTS; OBESITY; ADRENOCEPTOR; EXPRESSION; SUBTYPES; DRUGS;

D O I：

10.1016/j.bmc.2009.06.031

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In the search for potent and selective human beta 3-adrenergic receptor (AR) agonists as potential drugs for the treatment of obesity and noninsulin-dependent (type II) diabetes, we prepared a novel series of phenoxypropanolamine derivatives containing the thiourea moiety and evaluated their biological activities at human beta 3-, beta 2-, and beta 1-ARs. Among these compounds, 4-nitrophenylthiourea (18i) and 3-methoxyphenylthiourea (18k) derivatives were found to exhibit potent agonistic activity at the b3-AR, with EC(50) values of 0.10 and 0.16 mu M, respectively, and no agonistic activity for either the beta 1-or beta 2-AR. In addition, they showed significant hypoglycemic activity in a rodent diabetic model. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：5510 / 5519

页数：10

共 50 条

[21] The Tertiary Amine Nitrogen Atom of Piperazine Sulfonamides as a Novel Determinant of Potent and Selective β3-Adrenoceptor Agonists
Perrone, Maria Grazia
Bleve, Laura
Santandrea, Ernesto
Vitale, Paola
Niso, Mauro
Scilimati, Antonio
CHEMMEDCHEM, 2009, 4 (12) : 2080 - 2097
[22] Anti-obesity effects of selective agonists to the β3-adrenergic receptor in dogs.: II.: Recruitment of thermogenic brown adipocytes and reduction of adiposity after chronic treatment with a β3-adrenergic agonist
Sasaki, N
Uchida, E
Niiyama, M
Yoshida, T
Saito, M
JOURNAL OF VETERINARY MEDICAL SCIENCE, 1998, 60 (04) : 465 - 469
[23] Mutated human β3-adrenergic receptor (Trp64Arg) lowers the response to β3-adrenergic agonists in transfected 3T3-L1 preadipocytes
Kimura, K
Sasaki, N
Asano, A
Mizukami, J
Kayahashi, S
Kawada, T
Fushiki, T
Morimatsu, M
Yoshida, T
Saito, M
HORMONE AND METABOLIC RESEARCH, 2000, 32 (03) : 91 - 96
[24] Discovery and optimization of novel purines as potent and selective CB2 agonists
Hollinshead, Sean P.
Astles, Peter C.
Chambers, Mark G.
Johnson, Michael P.
Palmer, John
Tidwell, Michael W.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 4962 - 4966
[25] Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists
Kiefer, Lionel
Beaumard, Floriane
Gorojankina, Tatiana
Faure, Helene
Ruat, Martial
Dodd, Robert H.
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (04) : 554 - 569
[26] Discovery of Potent and Selective Agonists of δ Opioid Receptor by Revisiting the "Message-Address" Concept
Shen, Qing
Qian, Yuanyuan
Huang, Xiaoqin
Xu, Xuejun
Li, Wei
Liu, Jinggen
Fu, Wei
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (04): : 391 - 396
[27] Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists
He, Shuwen
Dobbelaar, Peter H.
Liu, Jian
Jian, Tianying
Sebhat, Iyassu K.
Lin, Linus S.
Goodman, Allan
Guo, Cheng
Guzzo, Peter R.
Hadden, Mark
Henderson, Alan J.
Ruenz, Megan
Sargent, Bruce J.
Yet, Larry
Kelly, Theresa M.
Palyha, Oksana
Kan, Yanqing
Pan, Jie
Chen, Howard
Marsh, Donald J.
Shearman, Lauren P.
Strack, Alison M.
Metzger, Joseph M.
Feighner, Scott D.
Tan, Carina
Howard, Andrew D.
Tamvakopoulos, Constantin
Peng, Qianping
Guan, Xiao-Ming
Reitman, Marc L.
Patchett, Arthur A.
Wyvratt, Matthew J., Jr.
Nargund, Ravi P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (06) : 1913 - 1917
[28] Mirabegron, a Selective β3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug
Dabrowska, Anna Maria
Dudka, Jaroslaw
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
[29] Insights into the binding modes of human β3-adrenergic receptor agonists with ligand-based and receptor-based methods
Jin, Fangfang
Lu, Chunhua
Sun, Xianqiang
Li, Weihua
Liu, Guixia
Tang, Yun
MOLECULAR DIVERSITY, 2011, 15 (04) : 817 - 831
[30] Potent and selective oxytocin receptor agonists without disulfide bridges
Sakimura, Yusuke Adachi Katsuya
Shimizu, Yuji
Nakayama, Masaharu
Terao, Yasuko
Yano, Takahiko
Asami, Taiji
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (11) : 2331 - 2335

← 1 2 3 4 5 →